TaraGregoryMD

PubMed

• 2 citations
  Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical Review.
  Paolo Strati, Tara Gregory, Navneet S Majhail, Nitin Jain> ;JCO Oncology Practice. 2023 Sep 1
• 2 citations
  Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.
  Furqan, F., Ahn, K., Chen, Y., Kaur, M., Abutalib, S., Ahmed, N., Ahmed, S., Kharfan-Dabaja, M., Friedberg, J., Gregory, T., Hill, L., Sterling, C., Barta, S., Shadman...> ;British Journal of Haematology. 2023 Jan 1
• 8 citations
  ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma.
  Binod Dhakal, Nina Shah, Ankit Kansagra, Ambuj Kumar, Sagar Lonial, Alfred Garfall, Andrew Cowan, Bishesh Sharma Poudyal, Caitlin Costello, Francesca Gay, Gordon Cook,...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• 14 citations
  Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies.
  Ali McBride, Steven Trifilio, Nadine Baxter, Tara K. Gregory, Scott C. Howard> ;Journal of the Advanced Practitioner in Oncology. 2017 Nov 1
• 14 citations
  Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Dis...
  George Chen, Paul A. Carpenter, Raewyn Broady, Tara K. Gregory, Laura Johnston, Barry E. Storer, Jan H. Beumer, Jingxin Qiu, Kiara Cerda, Ryan Le, Joanne Otani, Hong L...> ;Biology of Blood and Marrow Transplantation. 2018 Feb 1
• Molecular Phylogenetic Analysis of Infidum similis, Including Morphological Data and Estimation of its Genome Size.
  Martà Nez-Salazar, E. A.,Rosas-Valdez, R.,Gregory, T. R.,Violante-Gonzà Lez, J.> ;J. Parasitol.. 2016 Mar 22
• 74 citations
  Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.
  Scott C. Howard, Steven Trifilio, Tara K. Gregory, Nadine Baxter, Ali McBride> ;Annals of Hematology. 2016 Jan 12
• 97 citations
  Secondary solid cancer screening following hematopoietic cell transplantation.
  Y. Inamoto, Nirali N. Shah, Bipin N. Savani, Bronwen E. Shaw, Allistair Abraham, Ibrahim Ahmed, G. Akpek, Yoshiko Atsuta, K. S. Baker, Grzegorz W. Basak, Menachem Bita...> ;Bone Marrow Transplantation. 2015 Aug 8
• 99 citations
  Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics.
  Tara K Gregory, David N. Wald, Yichu Chen, Johanna M. Vermaat, Yin Xiong, William Tse> ;Journal of Hematology & Oncology. 2009 Jun 2
• Join now to see all

Abstracts/Posters

• A Phase 2 Study to Assess the Feasibility and Tolerance of the Combination of Elotuzumab, Lenalidomide, and Dexamethasone (ERd) in the Induction, Consolidation, and Ma...
  Tara K. Gregory, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Ixazomib or Lenalidomide Maintenance Following Autologous Stem Cell Transplantation and Ixazomib, Lenalidomide, and Dexamethasone (IRD) Consolidation in Patients with ...
  Tara K. Gregory, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)Clinically Relevant Abstract
  Tara K. Gregory, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Ixazomib-Lenalidomide-Dexamethasone (IRd) Consolidation Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Large Multi... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018